Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:BTEC

Principal Healthcare Innovators ETF (BTEC) Price, Holdings, & News

Principal Healthcare Innovators ETF logo

About Principal Healthcare Innovators ETF (NASDAQ:BTEC)

Key Stats

Today's Range
$39.49
$39.49
50-Day Range
$35.83
$41.10
52-Week Range
$25.66
$41.10
Volume
N/A
Average Volume
7,863 shs
Market Capitalization
$16.19 million
Assets Under Management
$16.16 million
Dividend Yield
1.14%
Net Expense Ratio
0.42%
Aggregate Rating
Buy

ETF Overview

The Principal Healthcare Innovators ETF (BTEC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to hold equities of small- and mid-cap healthcare firms in the US. The fund uses a proprietary, quantitative model to construct the portfolio. BTEC was launched on Aug 19, 2016 and is managed by Principal.

Principal Healthcare Innovators ETF Expenses

TypeBTECHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.42%0.57%0.55%0.49%0.52%
Other Expenses0.00%0.30%0.49%0.41%0.53%
Total Expense0.42%0.70%0.71%0.63%0.71%
Fee Waiver0.00%-0.45%-0.52%-0.32%-0.57%
Net Expense0.42%0.61%0.61%0.56%0.59%
Receive BTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Principal Healthcare Innovators ETF and its competitors with MarketBeat's FREE daily newsletter.

BTEC ETF News Headlines

BioNTech (BNTX) Presents at Innovation Series: AI Day
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
See More Headlines

BTEC ETF - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Principal Healthcare Innovators ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Micron Technology (MU), Quest Diagnostics (DGX), Dynavax Technologies (DVAX), iShares Biotechnology ETF (IBB) and Novavax (NVAX).

Fund Details

Issuer
Principal
Fund Name
Principal Healthcare Innovators ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:BTEC
Inception Date
8/19/2016
Fund Manager
Jeffrey A. Schwarte, Aaron J. Siebel
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
5

Fund Statistics

Assets Under Management
$16.16 million
Average Daily Volume
$703.80
Discount/Premium
0.08%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
Principal Global Investors, LLC
Custodian
State Street Bank and Trust Company
Distributor
ALPS Distributors, Inc.
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
1,500 shs

Miscellaneous

Beta
1.01
Creation Unit
50,000
Creation Fee
$600.00
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Top 5 BTEC Holdings

  • Us Dollar
    Holding Weight: 99.89%
  • Scilex (NASDAQ:SCLX)
    Holding Weight: 0.09%
  • Contra Chinook Therape Common Stock
    Holding Weight: 0.02%
  • Omniab
    Holding Weight: 0.00%
  • Omniab
    Holding Weight: 0.00%

This page (NASDAQ:BTEC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners